 |
Sept. 3, 2024 - Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Read
Aug. 1, 2024 - Puma Biotechnology Reports Second Quarter Financial Results
Read
July 18, 2024 - Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results
Read
June 3, 2024 - Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer
Read
June 2, 2024 - Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
Read
May 28, 2024 - Puma Biotechnology to Join Russell 3000 Index
Read
May 23, 2024 - Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
Read
May 2, 2024 - Puma Biotechnology Reports First Quarter Financial Results
Read
April 18, 2024 - Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results
Read
Mar. 20, 2024 - Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
Read
Feb. 29, 2024 - Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results
Read
Feb. 22, 2024 - Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference
Read
Feb. 15, 2024 - Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results
Read
Feb. 13, 2024 - Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II trial of Alisertib in Small Cell Lung Cancer
Read
Jan. 11, 2024 - Puma Biotechnology to Present at B. Riley Securities 4 th Annual Oncology Conference
Read
|
|
Upcoming Events
Sept. 9, 2024 - H.C. Wainwright 26th Annual Global Investment Conference
More
Past Events
Aug. 1, 2024 - Puma Biotechnology 2Q-2024 Financial Results Conference Call
More
May 31 - June 4, 2024 - ASCO 2024 Annual Meeting
More
May 2, 2024 - Puma Biotechnology 1Q-2024 Financial Results Conference Call
More
Mar. 6, 2024 - TD Cowen’s 44th Annual Health Care Conference
More
Feb. 29, 2024 - Puma Biotechnology 4Q-2023 Financial Results Conference Call
More
Jan. 11, 2024 - B. Riley Securities 4th Annual Oncology Conference
More
|
|
Annual Report Archives
Puma Biotechnology, Inc.
10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax
Medical Inquiries:
1-844-MED-PUMA (1-844-633-7862), or
medinfo@pumabiotechnology.com
Business Development:
info@pumabiotechnology.com
Investor Relations:
ir@pumabiotechnology.com
Follow Us:
|
